ライフサイエンスコーパス: glaucoma surgery

1 ed glaucoma who had previous cataract and/or glaucoma surgery.

2 despite additional medications or requiring glaucoma surgery.

3 ter 3 months, severe vision loss, or de novo glaucoma surgery.

4 liary space allowed concomitant cataract and glaucoma surgery.

5 Overall, 5 of 68 eyes (7%), required further glaucoma surgery.

6 =25 mm Hg; none required laser or incisional glaucoma surgery.

7 anent and require chronic medical therapy or glaucoma surgery.

8 ons, and had a lower requirement for further glaucoma surgery.

9 ntiglaucoma medications without any previous glaucoma surgery.

10 ical cohort of 100 000 patients who required glaucoma surgery.

11 en higher risk for elevated IOP and possibly glaucoma surgery.

12 No patients required glaucoma surgery.

13 of patients because of the need for further glaucoma surgery.

14 ed glaucoma who had previous cataract and/or glaucoma surgery.

15 visual acuity, complications, and additional glaucoma surgery.

16 cations) without complications or additional glaucoma surgery.

17 with or without medications, without further glaucoma surgery.

18 ss rates or change the complication rates of glaucoma surgery.

19 hthalmologists who do not perform incisional glaucoma surgery.

20 their assigned treatment and had additional glaucoma surgery.

21 echnique to treat hypotony maculopathy after glaucoma surgery.

22 tients (7/14); 3 eyes of 2 patients required glaucoma surgery.

23 justment for age, gender, CCT and history of glaucoma surgery.

24 to postoperative hypotony in eyes with prior glaucoma surgery.

25 nt cataract extraction, and 5 eyes underwent glaucoma surgery.

26 Five patients required glaucoma surgery.

27 es (12 Roper-Hall grade III or IV) underwent glaucoma surgery.

28 in eyes with previous cataract and/or failed glaucoma surgery.

29 s with previous cataract and/or unsuccessful glaucoma surgery.

30 ssure spikes that may necessitate additional glaucoma surgery.

31 lished literature relating to nonpenetrating glaucoma surgery.

32 fter trabeculectomy or combined cataract and glaucoma surgery.

33 quire oil removal with or without concurrent glaucoma surgery.

34 plications, including retinal, cataract, and glaucoma surgery.

35 ell as innovative techniques in cataract and glaucoma surgery.

36 l as for performing concomitant cataract and glaucoma surgery.

37 have vastly improved the results of combined glaucoma surgery.

38 nant of the final intraocular pressure after glaucoma surgery.

39 etermine predictors of undergoing incisional glaucoma surgery.

40 arm score can be used to quantify harm after glaucoma surgery.

41 es (6.0%) from 568 subjects (8.2%) underwent glaucoma surgery.

42 ith POAG without prior history of incisional glaucoma surgery.

43 ant features in predicting the occurrence of glaucoma surgery.

44 antiglaucomatous agents and no eyes required glaucoma surgery.

45 oma medications and less need for additional glaucoma surgery.

46 nutes) in patients with previous cataract or glaucoma surgery.

47 e in a less invasive manner than traditional glaucoma surgery.

48 nstant for at least 5 years after incisional glaucoma surgery.

49 rolled glaucoma and no history of incisional glaucoma surgery.

50 to monitor across time intervals containing glaucoma surgery.

51 ad a history of mitomycin use at the time of glaucoma surgery.

52 thickness, glaucoma medication use, or past glaucoma surgery.

53 heir POAG medically controlled without prior glaucoma surgery.

54 re associated with decreased odds of needing glaucoma surgery.

55 number of medications, and need for further glaucoma surgery.

56 Nineteen percent of the patients needed glaucoma surgery.

57 OP lowering medications and without need for glaucoma surgery.

58 and prognosis in conjunctival fibrosis after glaucoma surgery.

59 ar pressure and success of trabecular bypass glaucoma surgeries.

60 Six patients had undergone prior glaucoma surgeries.

61 ical challenges in patients with preexisting glaucoma surgeries.

62 rving superior bulbar conjunctiva for future glaucoma surgeries.

63 my or tube (traditional), and 4.6% had other glaucoma surgeries.

64 icant risk factors for combined cataract and glaucoma surgeries.

65 ey now account for a significant majority of glaucoma surgeries.

66 operative glaucoma medications, and previous glaucoma surgeries.

67 g with 5FU: 20.0% vs 23.7%, P > .99; further glaucoma surgery: 0% vs 13.2%, P = .15).

68 2.54 [IQR 1-4], P < .0001; median number of glaucoma surgeries, 1.0 [IQR 1-2] vs 1.25 [IQR 0.5-2.0],

69 e after cataract extraction (18/36, 50%) and glaucoma surgery (11/36, 31%).

70 n cause was secondary glaucoma or related to glaucoma surgery (12/22 eyes, 55%).

71 2.4 years), after an average of 4.4 +/- 2.4 glaucoma surgeries, 13 of 14 eyes had obtained IOP contr

72 etroprosthetic membrane formation, 21.6% for glaucoma surgery, 18.6% for retinal detachment, and 15.5

73 act surgery (34.9% vs 19.0%; P < .0001), and glaucoma surgery (28.7% vs 19.7%, P = .002).

74 ined EVFW had a higher likelihood of further glaucoma surgery (36%).

75 ngs were after cataract surgery (9/16, 56%), glaucoma surgery (4/16, 25%), and trauma (2/16, 13%).

76 olled, masked-observer study, after modified glaucoma surgery, 48 rabbits were randomly allocated to

77 with aniridia had more glaucoma (76.2%) and glaucoma surgery (57.1%) than comparison eyes (51.8%, P

78 rating keratoplasty, particularly with prior glaucoma surgery (58% with prior glaucoma surgery and us

79 surgery (10 eyes), and combined cataract and glaucoma surgery (7 eyes).

80 One hundred twenty-three of 1384 glaucoma surgeries (8.9%) to be performed by 4 glaucoma

81 Angle-based minimally invasive glaucoma surgery (ab-MIGS) has grown substantially, alth

82 20% of pre-existing glaucoma patients needed glaucoma surgery after a CRVO event, including 11.7% of

83 Two eyes (0.7%) required glaucoma surgery after DMEK.

84 2 years, 40 of 2435 eyes required incisional glaucoma surgery after LTP, and 51 of 2435 eyes required

85 The latter may necessitate glaucoma surgery after the resolved episode of the uveit

86 t surgery (aHR, 0.70; 95% CI 0.56-0.88), and glaucoma surgery (aHR, 0.63; 95% CI, 0.45-0.90).

87 A total of 117 697 eyes undergoing glaucoma surgery alone and 35 657 eyes undergoing surger

88 hment has been reported after nonpenetrating glaucoma surgery, although less endothelial loss is indu

89 The probability of glaucoma surgery among patients with pre-existing glauco

90 The adjusted rate ratio of glaucoma surgery among those who received 7 or more inje

91 tube shunt types and locations, and dates of glaucoma surgeries and anti-VEGF injections were collect

92 Seventy-four cases of glaucoma surgery and 740 controls were identified, with

93 review of glaucoma patients with traditional glaucoma surgery and at least 1 IVI before surgery.

94 ostoperative agent to prevent scarring after glaucoma surgery and compared it with 5-fluorouracil (5-

95 ion of eyes undergoing EK eventually require glaucoma surgery and experience graft-related complicati

96 model can be used to test key components of glaucoma surgery and implant design.

97 ed to determine success in recent studies of glaucoma surgery and makes recommendations about the mos

98 osis gene signature in the conjunctiva after glaucoma surgery and provides new insights into the mech

99 significant improvement in vision following glaucoma surgery and review the literature regarding thi

100 annually is associated with a higher risk of glaucoma surgery and that 4 to 6 injections per year sho

101 s of 626 patientson GLP-1R agonists and 1083 glaucoma surgery and treatment naive eyes of 547 patient

102 A total of 1247 glaucoma surgery and treatment naive eyes of 626 patient

103 with prior glaucoma surgery (58% with prior glaucoma surgery and use of medications to lower intraoc

104 y managed glaucoma, type and number of prior glaucoma surgeries, and occurrence of a rejection episod

105 athy, giant retinal tears, previous invasive glaucoma surgery, and <=90 days of follow-up were exclud

106 mber of antiglaucoma medications, history of glaucoma surgery, and employment status were recorded.

107 th proliferative vitreoretinopathy, previous glaucoma surgery, and giant retinal tears were excluded,

108 a lower failure rate, lower rate of de novo glaucoma surgery, and lower mean IOP on fewer medication

109 ians, comorbid glaucoma, concurrent or prior glaucoma surgery, and lower volumes of surgery are assoc

110 aocular pressure, thus preventing failure of glaucoma surgery, and may also act as a potential adjuva

111 toplasty in addition to history of glaucoma, glaucoma surgery, and prior graft failure or bullous ker

112 Twenty eyes required glaucoma surgery, and the average number of IOP-lowering

113 eedling with 5-fluorouracil (5FU) or further glaucoma surgery, and the incidence of complications rel

114 ng EK surgery; 2) time-to-event analysis for glaucoma surgery; and 3) occurrence of graft complicatio

115 odulators of the scarring response following glaucoma surgery are reviewed.

116 , and 13.8% of all eyes in this study needed glaucoma surgery at 1-, 5-, and 8-years of follow-up, re

117 The incidence of incisional glaucoma surgery at month 36 was 4.8% in the low-dose gr

118 y, 42 patients were recruited at the time of glaucoma surgery at the Moorfields Eye Hospital from Sep

119 eyes with preexisting glaucoma, 27 (38%) had glaucoma surgery before KPro (18 GDD), whereas 45 (62%)

120 ng CE (beta [SE] = 0.52 [0.07]), intervening glaucoma surgeries (beta [SE] = 0.15 [0.03]), and more p

121 ression was used to compare trends in use of glaucoma surgeries between ophthalmologists who could be

122 y) between 2013 and 2021, or did not undergo glaucoma surgery but had 3 or more ophthalmology visits.

123 a better safety profile with nonpenetrating glaucoma surgery but higher long-term intraocular pressu

124 Antifibrotics are potent adjuncts to glaucoma surgery, but along with their beneficial use ar

125 ical determinant of the long-term success of glaucoma surgery, but no reliable biomarkers are current

126 Most glaucoma surgery can adversely affect the cornea.

127 A system for robot-assisted microinvasive glaucoma surgery can successfully achieve implantable an

128 egeneration, diabetic retinopathy, cataract, glaucoma surgery, cataract surgery, and first-order inte

129 VF loss included older age, non-white race, glaucoma surgery, cataract surgery, and moderate baselin

130 Risk of glaucoma surgery compared with the number of intravitreo

131 nimum of 20% of IOP reduction and no further glaucoma surgery (complete success: without the need of

132 Nonpenetrating glaucoma surgery continues to evolve.

133 The total number of traditional incisional glaucoma surgeries decreased by 11.7%, from 37 225 to 32

134 , survival of corneal grafts, and success of glaucoma surgery (defined as IOP of 5-20 mm Hg and no ad

135 rgery with the ab externo minimally invasive glaucoma surgery device Preserflo MicroShunt with mitomy

136 vine, California, USA), a minimally invasive glaucoma surgery device, in refractory glaucoma.

137 In eyes with prior glaucoma surgery, DMEK achieved good long-term visual ou

138 In eyes with previous glaucoma surgery, DMEK has good early outcomes, but long

139 In complex eyes with prior glaucoma surgery, DMEK offers faster visual recovery, be

140 age of ophthalmologists providing incisional glaucoma surgery dropped from 35% in 1995 to 19% in 2010

141 As interventions like minimally invasive glaucoma surgeries evolve, the role of glaucoma medical

142 participants (67%) had previously undergone glaucoma surgery (fibrotic group) (mean [SD] age, 43.8 [

143 To determine the risk of glaucoma surgery following repeated intravitreous bevaci

144 ity of OCT neuroretinal rim parameters after glaucoma surgery for ongoing detection of glaucoma progr

145 V's on the IOP and on the risk of undergoing glaucoma surgery, for each of the indications for PPV.

146 en-angle glaucoma and no previous incisional glaucoma surgery from 9 glaucoma units were evaluated re

147 d preexisting glaucoma (G), and 46 had prior glaucoma surgery (GS).

148 ucoma, and those who had undergone 3 or more glaucoma surgeries had significantly lower FVA and VR Qo

149 Age of the patient and glaucoma surgery had an influence on corneal thickness.

150 ion of ophthalmologists providing incisional glaucoma surgery has declined significantly.

151 Glaucoma surgery has evolved over the past 30 years from

152 Performing cataract extraction prior to glaucoma surgery has numerous benefits.

153 ouracil and mitomycin C, in conjunction with glaucoma surgery has resulted in lower postoperative int

154 However, other corneal effects of glaucoma surgery have also been reported.

155 Glaucoma surgery have been developed to lower intraocula

156 Outflow procedures for glaucoma surgery have remained popular in the last decad

157 agnosis (HR: 1.53; 95% CI: 1.46-1.60), prior glaucoma surgery (HR: 1.26; 95% CI: 1.18-1.35), and conc

158 HR: 1.26; 95% CI: 1.18-1.35), and concurrent glaucoma surgery (HR: 1.31; 95% CI: 1.20-1.44).

159 light perception, requirement for additional glaucoma surgery, hypotony maculopathy, and serious comp

160 Prior incisional glaucoma surgery imparted a 3.15 times greater risk of r

161 ucoma, precluding the need for more invasive glaucoma surgery in >80% of patients at 1 year, thereby

162 Two infants underwent glaucoma surgery in 1 eye and demonstrated acute hydrops

163 red in 28% of first enrolled eyes (including glaucoma surgery in 10%).

164 d with improved success rates of traditional glaucoma surgery in glaucoma patients who received IVIs

165 gery after LTP, and 51 of 2435 eyes required glaucoma surgery in the comparison group (P = 0.27, adju

166 enhance intraocular pressure reduction after glaucoma surgery in the future.

167 = 0.02) and more cases with prior ab externo glaucoma surgery in the MicroShunt group (19% vs. 3% in

168 em modifications after completely successful glaucoma surgery in thirty-eight patients undergoing tra

169 sions and optic disc cupping, and no further glaucoma surgery (including needling) or loss of light p

170 Recent modifications in nonpenetrating glaucoma surgery, including the use of implants, augment

171 hthalmologists who do not perform incisional glaucoma surgery increased 19.3% annually (P < .0001), w

172 hthalmologists who do not perform incisional glaucoma surgery increased at average annual rates of 1.

173 luding prior penetrating keratoplasty, prior glaucoma surgery, iridocorneal endothelial syndrome, ani

174 ical outcomes were observed after additional glaucoma surgery, irrespective of initial randomized tre

175 PAC disease, for which combined cataract and glaucoma surgery is indicated.

176 Following CRVO, glaucoma surgery is necessary for pre-existing glaucoma

177 ns and enhancements, traditional penetrating glaucoma surgery is not without complications and is res

178 Complication rates are not increased when glaucoma surgery is performed in KPro eyes with either p

179 Nonpenetrating glaucoma surgery is popular in a number of countries bec

180 ression suggests critical ages where further glaucoma surgery is required at around 2 and 5 years of

181 s proven to be an alternative to traditional glaucoma surgery, lowering IOP relatively well.

182 undergoing cataract removal after successful glaucoma surgery maintained IOP control.

183 tinue to perform most traditional incisional glaucoma surgeries, many MIGS procedures are performed b

184 ve medication and had no previous history of glaucoma surgery (medical group), while 32 eyes with ope

185 Micro- or minimally invasive glaucoma surgeries (MIGS) have been the latest addition

186 plants (GDIs), and select minimally invasive glaucoma surgeries (MIGS) including the iStent, were que

187 rgery (71.9%), while 16.2% had microinvasive glaucoma surgeries (MIGS), 6.5% had a trabeculectomy or

188 Compared with microinvasive glaucoma surgery (MIGS), tube shunts were the only surge

189 e implant [GDI] procedure) and microinvasive glaucoma surgery (MIGS).

190 aft a position statement about microinvasive glaucoma surgery (MIGS).

191 n eyes originally indicated for conventional glaucoma surgery, no secondary surgery was performed in

192 ticipants (33%) had not previously undergone glaucoma surgery (nonfibrotic group) (mean [SD] age, 47.

193 included trabeculectomy and non-penetrating glaucoma surgery (NPGS) with mitomycin-C.

194 Fifteen eyes that underwent glaucoma surgery obtained IOP control, and GDD with or w

195 0.009), and between the number of PPV's and glaucoma surgery (odds ratio [95% confidence interval]:

196 with significantly increased odds of needing glaucoma surgery (odds ratio [OR] = 1.09, P < .001).

197 itiation of ocular hypotensive medication or glaucoma surgery of any kind.

198 y is to compare the effectiveness of various glaucoma surgeries on intraocular pressure (IOP) managem

199 er among eyes that had undergone cataract or glaucoma surgery or both (n = 28; P = 0.0004).

200 Human AH was obtained at the time of either glaucoma surgery or cataract extraction.

201 r and posterior segments combined surgery or glaucoma surgery or complex posterior segment surgery we

202 2 mm Hg and 20% reduction without additional glaucoma surgery or devastating complication.

203 jects were excluded if they had had previous glaucoma surgery or laser and also if intraocular surger

204 he time of surgery vs 22% with no history of glaucoma surgery or medication use; HR, 4.1 [99% CI, 2.2

205 ter excluding participants with a history of glaucoma surgery or medication, refractive surgery, corn

206 below medicated baseline without additional glaucoma surgery or medications.

207 result of intraoperative surgical trauma in glaucoma surgery or postoperatively with chronic endothe

208 After exclusion of individuals after glaucoma surgery or with antiglaucomatous therapy, mean

209 p with age (OR: 1.04; p < 0.001), history of glaucoma surgery (OR:2.75; p < 0.001), pseudophakia (OR:

210 sequent operative intervention or additional glaucoma surgery, or a catastrophic event such as loss o

211 glaucoma, angle closure, previous incisional glaucoma surgery, or any significant ocular pathology ot

212 t reduced by 20%, IOP </=5 mm Hg, additional glaucoma surgery, or loss of light perception vision).

213 fter the first 6 weeks after surgery, repeat glaucoma surgery, or loss of light perception.

214 ns increased with more severe VF loss, prior glaucoma surgery, or younger age.

215 t the clinical relevance of such findings on glaucoma surgery outcomes remains unknown.

216 went cataract surgery and 79 (4.8%) received glaucoma surgery over the 2-year follow-up.

217 ouracil and mitomycin C, have revolutionized glaucoma surgery over the past decade.

218 n FVA and P = .009 in VR QoL), and 3 or more glaucoma surgeries (P < .001 for both FVA and VR QoL).

219 e correlated; in a multivariate model, prior glaucoma surgery (P < 0.0001) and a prior rejection epis

220 igher risk of IOP elevation and the need for glaucoma surgery (P = .003, P < .001, and P < .001, resp

221 laucoma medications (P = .003) or to undergo glaucoma surgery (P = .016) than Roper-Hall grade I or I

222 ed in 35.8% of eyes and correlated with AXL, glaucoma surgery, patchy atrophy, MNM, and MTM developme

223 A higher number of glaucoma surgeries per patient was identified as an asso

224 nalyzed to identify all laser and incisional glaucoma surgeries performed from 2008 through 2016.

225 e same period, the mean number of incisional glaucoma surgeries performed per surgeon doubled, and th

226 Among the latter, 19 (42%) needed glaucoma surgery post-KPro (16 GDD).

227 28 eyes with de novo glaucoma, 12 (43%) had glaucoma surgery post-KPro (9 GDD).

228 , bilateral uveitis, prior cataract surgery, glaucoma surgery, presence of keratic precipitates and s

229 Collectively, the use of new microinvasive glaucoma surgery procedures has increased rapidly such t

230 the same time, the proportion of incisional glaucoma surgery provided by high-volume glaucoma surgeo

231 about activities correlated with history of glaucoma surgery (r = 0.148; P = .023) and VF MD of the

232 OP] target of 6-18 mm Hg inclusive), de novo glaucoma surgery rates, mean IOP, mean glaucoma medicati

233 Glaucoma surgeries reduce IOP by facilitating aqueous hu

234 In addition, the sequencing of glaucoma surgery relative to penetrating keratoplasty af

235 ines from patients with and without previous glaucoma surgery, respectively.

236 ual acuity (BCVA), type of glaucoma, type of glaucoma surgeries RESULTS: Fourteen of 97 patients (14%

237 the use of antifibrotic agents adjunctive to glaucoma surgery, reviews recently published studies tha

238 and intervening cataract extraction (CE) or glaucoma surgery, scan quality, baseline RNFLT and RNFLT

239 Despite the advent of many new devices for glaucoma surgery, scarring is the main cause of suboptim

240 Glaucoma surgery should be offered early to those with a

241 were divided into 3 groups: eyes with prior glaucoma surgery (ST), eyes with medically treated glauc

242 mong 40 eyes for which Trab360 was the first glaucoma surgery, success rate was 70% (95% CI 53.3%-82.

243 18 PCG eyes for which Trab360 was the first glaucoma surgery, success rate was 83.3% (95% CI 57.7%-9

244 Compared to traditional glaucoma surgeries, such as trabeculectomy and glaucoma

245 ngle glaucoma (OAG) had previously undergone glaucoma surgery (surgical group).

246 We assessed use of traditional incisional glaucoma surgery techniques (trabeculectomy and glaucoma

247 Recently introduced microincisional glaucoma surgeries that enhance conventional outflow off

248 issue with regard to coincident cataract and glaucoma surgery, that is, the indications for the proce

249 , long-term results of combined cataract and glaucoma surgery, the survival of filtration blebs after

250 hift in practice from traditional incisional glaucoma surgeries to MIGS procedures was observed.

251 %) than in the eye drops group (91.3%), with glaucoma surgery to lower intraocular pressure required

252 cular pressure could lead to higher rates of glaucoma surgery to lower this pressure.

253 From glaucoma surgery to the management of various corneal di

254 Ophthalmologists commonly perform glaucoma surgery to treat progressive glaucoma.

255 e laser trabeculoplasty (SLT) and eventually glaucoma surgery (Trabectome) in 2 eyes for disease mana

256 thy attributable to overfiltration following glaucoma surgery (trabeculectomy with mitomycin C) were

257 s for glaucoma (including minimally invasive glaucoma surgeries, trabeculectomy, or glaucoma drainage

258 e glaucoma patients without prior incisional glaucoma surgery undergoing phacoemulsification by a sin

259 medical therapy, without previous incisional glaucoma surgery underwent trabeculectomy (85 eyes) or c

260 train new models for predicting the need for glaucoma surgery using multivariable logistic regression

261 ure at 1, 2, 3, and 4 years after additional glaucoma surgery was 0%, 43%, 43%, and 43%, respectively

262 Mean age +/- standard deviation at initial glaucoma surgery was 11.1 +/- 4.4 years with a follow-up

263 Follow-up (mean +/- SD) after additional glaucoma surgery was 28.0 +/- 16.0 months in the tube gr

264 Previous glaucoma surgery was associated with a significantly inc

265 us associated with binocular diplopia due to glaucoma surgery was hypertropia (10/11 GDD cases, 2/2 t

266 The cumulative probability of incisional glaucoma surgery was lower in the microstent group (0.6%

267 Additional glaucoma surgery was needed more frequently after trabec

268 Secondary glaucoma surgery was performed in 2 eyes in the 2-iStent

269 and 15.0% (95% CI, 11.8-19.1) respectively; glaucoma surgery was performed in 2.4% of eyes (95% CI,

270 Additional glaucoma surgery was performed in 21 patients in the tub

271 Additional glaucoma surgery was performed in 8 patients in the tube

272 led and were censored when additional SLT or glaucoma surgery was performed.

273 Further glaucoma surgery was required for 33 eyes.

274 Additional glaucoma surgery was required in 1 eye (in the cataract

275 ason for failure in both groups, and de novo glaucoma surgery was required in 16% of the Ahmed group

276 Further glaucoma surgery was required in 5.5% (3) in MCT and 63.

277 Also, the number of eyes that underwent glaucoma surgery was significantly higher compared to th

278 diplopia and binocular diplopia unrelated to glaucoma surgery was similar among medical and surgical

279 lure of medical treatment in controlling the glaucoma, surgery was offered to the patient.

280 Patients who underwent additional glaucoma surgery were censored in the survival analysis.

281 Patients requiring further glaucoma surgery were considered failures.

282 .31; 95% CI, 0.20-0.47), whereas the odds of glaucoma surgery were elevated in surgical patients with

283 at baseline and candidates for conventional glaucoma surgery were enrolled.

284 No differences in need for glaucoma surgery were noted among those with OAG who wer

285 glaucoma medication, or not having undergone glaucoma surgery) were identified.

286 dvanced disease and who had either undergone glaucoma surgery, were receiving medical treatment, or h

287 es of sight-threatening events and secondary glaucoma surgery when compared with control.

288 itomycin-C trabeculectomy and nonpenetrating glaucoma surgery, when the most recent modification has

289 l stent is an ab-interno, minimally invasive glaucoma surgery which provides a subconjunctival draina

290 Penetrating glaucoma surgery will continue to evolve.

291 Thirty-one eyes of 18 patients required glaucoma surgery with 2.2 +/- 1.2 IOP-lowering surgeries

292 All eyes required glaucoma surgery with 91% requiring multiple surgeries (

293 of patients with conjunctival fibrosis after glaucoma surgery with candidate gene expression tissue b

294 Combining glaucoma surgery with minimal invasive phacoemulsificati

295 cally reviews recent advances in penetrating glaucoma surgery with particular attention paid to two n

296 gher for both glaucoma and combined cataract/glaucoma surgeries, with the highest incidence among tub

297 scriptions and had no cataract or additional glaucoma surgery within 2 years after LPIs.

298 roportion of enrollees requiring cataract or glaucoma surgery within 2 years after the LPIs were dete

299 ture as it pertains to combined cataract and glaucoma surgery within the 1-year scanning period.

300 lysis of 1582 eyes that underwent incisional glaucoma surgery yielded a 5-year cumulative incidence f